155 related articles for article (PubMed ID: 23144197)
1. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.
Omidvar N; Maunakea ML; Jones L; Sevcikova S; Yin B; Himmel KL; Tennant TR; Le Beau MM; Largaespada DA; Kogan SC
Haematologica; 2013 Mar; 98(3):424-7. PubMed ID: 23144197
[TBL] [Abstract][Full Text] [Related]
2. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.
Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM
Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899
[TBL] [Abstract][Full Text] [Related]
3. Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.
Aue G; Du Y; Cleveland SM; Smith SB; Davé UP; Liu D; Weniger MA; Metais JY; Jenkins NA; Copeland NG; Dunbar CE
Blood; 2011 Oct; 118(17):4674-81. PubMed ID: 21878674
[TBL] [Abstract][Full Text] [Related]
4. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
[TBL] [Abstract][Full Text] [Related]
5. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
Le Beau MM; Bitts S; Davis EM; Kogan SC
Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
[TBL] [Abstract][Full Text] [Related]
6. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
[TBL] [Abstract][Full Text] [Related]
7. Sox4 cooperates with CREB in myeloid transformation.
Sandoval S; Kraus C; Cho EC; Cho M; Bies J; Manara E; Accordi B; Landaw EM; Wolff L; Pigazzi M; Sakamoto KM
Blood; 2012 Jul; 120(1):155-65. PubMed ID: 22627767
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation.
Phan VT; Shultz DB; Truong BT; Blake TJ; Brown AL; Gonda TJ; Le Beau MM; Kogan SC
Mol Cell Biol; 2003 Jul; 23(13):4573-85. PubMed ID: 12808098
[TBL] [Abstract][Full Text] [Related]
9. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
Sohal J; Phan VT; Chan PV; Davis EM; Patel B; Kelly LM; Abrams TJ; O'Farrell AM; Gilliland DG; Le Beau MM; Kogan SC
Blood; 2003 Apr; 101(8):3188-97. PubMed ID: 12515727
[TBL] [Abstract][Full Text] [Related]
10. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
11. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
[TBL] [Abstract][Full Text] [Related]
12. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
13. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
[TBL] [Abstract][Full Text] [Related]
14. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
[TBL] [Abstract][Full Text] [Related]
15. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
16. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
17. Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.
Agrawal-Singh S; Koschmieder S; Gelsing S; Stocking C; Stehling M; Thiede C; Thoennissen NH; Köhler G; Valk PJ; Delwel R; Mills K; Bäumer N; Tickenbrock L; Hansen K; Berdel WE; Müller-Tidow C; Serve H
Blood; 2010 Jun; 115(22):4507-16. PubMed ID: 20215640
[TBL] [Abstract][Full Text] [Related]
18. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
19. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
Du C; Redner RL; Cooke MP; Lavau C
Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]